zileuton
Selected indexed studies
- Zileuton. (, 2012) [PMID:31643716]
- Zileuton. (, 2006) [PMID:30000545]
- The ALOX5 inhibitor Zileuton regulates tumor-associated macrophage M2 polarization by JAK/STAT and inhibits pancreatic cancer invasion and metastasis. (Int Immunopharmacol, 2023) [PMID:37348233]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Zileuton. (2012) pubmed
- Zileuton. (2006) pubmed
- The ALOX5 inhibitor Zileuton regulates tumor-associated macrophage M2 polarization by JAK/STAT and inhibits pancreatic cancer invasion and metastasis. (2023) pubmed
- Zileuton. (2026) pubmed
- Zileuton. (1996) pubmed
- Zileuton: the first 5-lipoxygenase inhibitor for the treatment of asthma. (1996) pubmed
- Zileuton protects against arachidonic acid/5-lipoxygenase/leukotriene axis-mediated neuroinflammation in experimental traumatic brain injury. (2025) pubmed
- Zileuton ameliorates aminoglycoside and polymyxin-associated acute kidney injury in an animal model. (2023) pubmed
- Synergistic effects of AgNPs and zileuton on PCOS via ferroptosis and inflammation mitigation. (2025) pubmed
- Zileuton use and phenotypic features in asthma. (2020) pubmed